US Stock MarketDetailed Quotes

Intellia Therapeutics (NTLA)

Watchlist
  • 11.740
  • +0.310+2.71%
Close Jan 13 16:00 ET
  • 11.840
  • +0.100+0.85%
Post 19:01 ET
1.36BMarket Cap-2.76P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intellia Therapeutics (NTLA) Earnings Dates, Reports & Conference Call

NTLA 2025 Q3 Earnings Dates & Summary

Currency：USD--

Estimate
(YoY) 		Actual
(YoY) 		Vs Estimate
(% Chg)
Revenue
14.12M
13.78M
-342.47K
Miss Est.
+55.03%
+51.27%
-2.42%
EPS
-0.976
-0.92
+0.056
Beat Est.
+27.15%
+31.34%
+5.75%
Analyst Rating
Buy

Jan 13, 2026

NTLA Revenue, EPS and EBIT Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 10.358M--
--2025/Q4-- / 12.173M--
--2025/Q313.782M / 14.124M--
Aug 7, 20252025/Q214.245M / 12.163M--
May 8, 20252025/Q116.627M / 11.986M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 10.358M--
--2025/Q4-- / 12.173M--
--2025/Q313.782M / 14.124M--
Aug 7, 20252025/Q214.245M / 12.163M--
May 8, 20252025/Q116.627M / 11.986M--

Unlock Free Earnings Estimates

Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +10.53%
Sample Name
Sample Code
 +2.79%
Sample Name
Sample Code
 +1.62%
4
Alphabet-A
GOOGL
+1.24%
5
Palo Alto Networks
PANW
+1.04%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.38%
Sample Name
Sample Code
 +15.02%
Sample Name
Sample Code
 +12.40%
4
Alibaba
BABA
+10.68%
5
Legend Biotech
LEGN
+7.58%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -